Exploration of a xenograft model of human prostate cancer to predict patient treatment response
For several years, docetaxel was the only treatment to improve survival of patients with metastatic prostate cancer. There are now many novel agents available but the optimal sequence of treatments remains undefined. The emergence of prostate cancer stem cells has brought a new way to elucidate the...
| Main Author: | |
|---|---|
| Published: |
University of Hull
2014
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.679629 |